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Stage-specific control of neural crest stem cell proliferation by
the small rho GTPases Cdc42 and Rac1
Abstract
The neural crest (NC) generates a variety of neural and non-neural tissues during vertebrate
development. Both migratory NC cells and their target structures contain cells with stem cell features.
Here we show that these populations of neural crest-derived stem cells (NCSCs) are differentially
regulated by small Rho GTPases. Deletion of either Cdc42 or Rac1 in the NC results in size reduction of
multiple NC target structures because of increased cell-cycle exit, while NC cells emigrating from the
neural tube are not affected. Consistently, Cdc42 or Rac1 inactivation reduces self-renewal and
proliferation of later stage, but not early migratory NCSCs. This stage-specific requirement for small
Rho GTPases is due to changes in NCSCs that, during development, acquire responsiveness to
mitogenic EGF acting upstream of both Cdc42 and Rac1. Thus, our data reveal distinct mechanisms for
growth control of NCSCs from different developmental stages.
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The neural crest (NC) generates a variety of neural and non-neural tissues during 
vertebrate development. Both migratory NC cells and their target structures 
contain cells with stem cell features. Here we show that these populations of neural 
crest-derived stem cells (NCSCs) are differentially regulated by small Rho GTPases. 
Deletion of either Cdc42 or Rac1 in the NC results in size reduction of multiple NC 
target structures because of increased cell cycle exit, while NC cells emigrating from 
the neural tube are not affected. Consistently, Cdc42 or Rac1 inactivation reduces 
self-renewal and proliferation of later stage, but not early migratory NCSCs. This 
stage-specific requirement for small Rho GTPases is due to changes in NCSCs that 
during development acquire responsiveness to mitogenic EGF acting upstream of 
both Cdc42 and Rac1. Thus, our data reveal distinct mechanisms for growth control 
of NCSCs from different developmental stages.
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Introduction
The neural crest (NC) is a transient population of cells in higher vertebrates that during 
embryonic development emigrates from the dorsal neural tube to generate most of the 
peripheral nervous system and a variety of non-neural structures (Le Douarin and Dupin, 
2003). Among fate-restricted cells, the NC harbors many cells termed neural crest stem 
cells (NCSCs) that display self-renewal capacity and multipotency in clonal cell culture 
assays. Intriguingly, very similar cells in terms of marker expression and potential have 
also been isolated from NC-derived structures during fetal development and even from 
the adult organism (Delfino-Machin et al., 2007). In vivo fate mapping revealed a 
lineage-relationship between early, emigrating (e)NCSCs and NCSCs found at later 
stages (Wong et al., 2006). These findings suggest that a fraction of undifferentiated 
NCSCs must be maintained by self-renewal throughout development and postnatal 
stages, while other NC progeny undergo fate restriction, eventually exit the cell cycle, 
and differentiate. The mechanisms regulating NCSC maintenance and proliferation are 
only partially understood. In Xenopus, the transcriptional regulator Id3 is essential for NC 
formation from the neural plate and promotes proliferation and expansion of the NC 
domain (Kee and Bronner-Fraser, 2005). At similarly early stages of murine NC 
development, combinatorial Wnt and BMP suppress differentiation and, in the presence 
of FGF2, maintain mitotic eNCSCs (Kleber et al., 2005). However, NCSCs from sciatic 
nerves and dorsal root ganglia lose Wnt responsiveness, pointing to distinct mechanisms 
of growth control in different NCSC populations. At later stages, NC-derived stem and 
progenitor cells from the gut and the skin are maintained by endothelin 3 signalling or by 
the activity of the polycomb group transcriptional repressor Bmi-1 (Bondurand et al., 
Small Rho GTPases in neural crest development – Fuchs et al 4
2006; Molofsky et al., 2003; Real et al., 2006), but the relatively mild or lineage-specific 
phenotypes of the respective mouse mutants do not support a general and indispensable 
role of these factors in NCSC expansion.
Cdc42 and Rac1 are ubiquitously expressed small Rho GTPases that act as molecular 
switches, cycling between an active GTP-bound and an inactive GDP-bound state (Jaffe 
and Hall, 2005). Rho GTPases play a central role in linking extracellular stimuli with the 
induction of multiple specific downstream effectors resulting in a variety of cellular 
responses. These include effects on cell polarity, migration, differentiation, proliferation 
and apoptosis (Jaffe and Hall, 2005). Earlier studies have largely relied on 
pharmacological inhibition of Rho GTPases or on expression of dominant-negative or 
constitutively active forms. Although these studies have been fundamental for the 
understanding of basic Rho GTPase biology, these approaches are potentially non-
specific due to cross-activation or inhibition of other effectors. Moreover, being central 
molecules within a plethora of signaling pathways, Rho GTPase function can 
significantly vary from one cell type to another. To analyse a given Rho GTPase in a 
specific cell type in an in vivo setting, conditional gene targeting of specific Rho GTPases 
in transgenic mice has therefore become the method of choice (Wang and Zheng, 2007). 
Knowledge about the roles of Rho GTPases in NC development is still limited. RhoV has 
been identified as an essential regulator of NC induction in Xenopus (Guemar et al., 
2007). Recently, pharmacological inhibition of Cdc42/Rac1 was reported to affect 
migration and neurite extension of NC-derived cells in the enteric nervous system (ENS) 
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(Stewart et al., 2007). Here we performed gene ablation in the NC and find that Cdc42
and Rac1 are not required for maintenance, migration and differentiation of NCSCs in the 
early phase of NC development. However, at later stages when NC cells have reached 
their initial targets, proliferation control becomes dependent on Cdc42 and Rac1. Thus, 
Cdc42 and Rac1 are essential regulators of NC development that distinguish NCSCs from 
different stages.
Results
Inactivation of Cdc42 or Rac1 in NC cells
To assess the functions of Cdc42 and Rac1 in NC cells in vivo, we crossed mice 
homozygous for the floxed allele of either Cdc42 or Rac1 (Chrostek et al., 2006; Wu et 
al., 2006) with mice heterozygous for the respective allele, which additionally expressed 
the Cre recombinase under control of the Wnt1 promoter (Danielian et al., 1998) (Fig. 
1A,B). Wnt1-Cre-mediated recombination efficiently deletes genes of interest in virtually 
the entire NC population (Lee et al., 2004; Wurdak et al., 2005). Efficiency of 
recombination was verified by genomic PCR, amplifying distinct fragments for wild 
type, floxed, or null alleles of Cdc42 and Rac1, respectively (Supplementary Fig. 1). In 
Wnt1-Cre/Cdc42lox/lox and Wnt1-Cre/Rac1lox/lox embryos the respective null allele was 
only observed in NC target tissue, whereas PCR amplification from non-recombined 
tissue was negative for the null allele, demonstrating that expression of the Cre-
recombinase was tissue-specific. Immunohistochemistry revealed significantly reduced 
expression of Cdc42 and Rac1 protein in recombined areas of the respective mutants 
(Fig. 1C,D).
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Cdc42 and Rac1 depletion cause multiple defects in NC derivatives
Both Cdc42 and Rac1 conditional knock out (cko) embryos were recovered up to 
embryonic day (E)13.5 with a Mendelian ratio, whereas litters from later developmental 
stages contained no mutant embryos (Supplementary Fig. 1). At E10.5 the gross 
morphology of Rac1 cko embryos showed no obvious malformations. Cdc42 cko 
embryos appeared also normal except for slight abnormalities in the mid-hindbrain 
region, where Wnt1-Cre is also expressed. These deficiencies appeared similar to those 
previously described for the developing central nervous system (CNS) lacking Cdc42
(Cappello et al., 2006; Chen et al., 2006). At later stages than E10.5, the phenotypes of 
Cdc42 and Rac1 cko embryos appeared to be similar, with severe malformations in NC 
target tissues evident in both mutants (Fig. 1E-G). Craniofacial development was 
drastically impaired, as manifested by a facial cleft. Although initial palatal shelve 
formation appeared normal, palatal shelves developed poorly from E10.5 onwards and 
failed to fuse. Constituents of the peripheral nervous system (PNS), such as dorsal root 
ganglia (DRG) and other ganglia of the sensory-somatic and autonomic nervous system 
were present but appeared all underdeveloped and reduced in size (Fig. 1F; data not 
shown). During normal development the heart outflow tract becomes divided into the 
aortic and pulmonary outflow vessels via formation of the aortico-pulmonary septum 
from the cardiac NC (Fig. 1G). In contrast, the aortico-pulmonary septum failed to form 
in both mutants leading to a defect known as truncus arterious (TA), which is often seen 
upon impaired development of the NC cell pool that contributes to heart outflow tract 
formation (Wurdak et al., 2006).
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Emigration of NC cells from neural tube to initial target structures appears not to be 
affected by loss of Cdc42 and Rac1
As we observed abnormalities in all NC derivatives examined, Cdc42 and Rac1 are likely 
to fulfill general rather than lineage-specific roles in NC development. Rho GTPase 
function has been linked to cell migration and adhesion (Fukata et al., 2003). Therefore, 
we first investigated whether lack of Cdc42 and Rac1 might lead to defective NC cell 
migration. Upon Wnt1-Cre-mediated recombination of the ROSA26 Cre reporter allele 
(R26R) (Soriano, 1999), -galactosidase is stably expressed in NC cells and their 
progeny, which allows in vivo fate mapping of control and mutant NC cells (Hari et al., 
2002; Ittner et al., 2005). Using this system, we did not detect major migration deficits of 
both Cdc42- and Rac1-deficient NC cells at E10.5 in craniofacial areas, into the 
pharyngeal arches (PA), and in the trunk (Fig. 2A,B). Moreover, at later stages, control 
and mutant NC cells have reached their initial targets, including nasofrontal structures, 
the eye, peripheral ganglia and nerves, and the proximal gut (Fig. 2C-F; data not shown). 
However, in the mutants, ganglia were smaller and distal parts of the gut lacked NC cell 
colonization, indicative for reduced numbers of NC-derived cells present in these 
structures (Simpson et al., 2007). 
To confirm and quantify the migratory capacity of control and mutant NC cells at early 
stages of NC development, we generated NC cell explants in vitro from neural tubes 
isolated at E9.5 (Lee et al., 2004). In this defined cell culture system the extent of NC 
outgrowth can be assessed 20 hours after initiation of the cultures. The explants formed 
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from Cdc42 and Rac1 cko neural tubes were highly similar to their respective control 
explants. Quantification of the outgrowth area (Hari et al., 2002) did not reveal 
differences between control and cko explants (Supplementary Fig. 2) and the cell density 
per area was not changed in mutant explants (data not shown). Thus, impaired emigration 
from the neural tube is not a primary cause of the phenotype observed in Cdc42 and Rac1 
cko embryos.
Cdc42 and Rac1 are not required for differentiation of NC cells
Apart from migration, failure of NC cells to properly differentiate might contribute to the 
Cdc42 and Rac1 cko phenotype. Possibly, loss of Cdc42 and Rac1 might interfere with 
cell fate decisions in the NC population, favoring differentiation into a specific lineage at 
the expense of other fates. However, as apparently all examined NC-derived structures 
were affected, differentiation might rather be impaired at a global level than at the level 
of distinct lineages. Therefore, we investigated whether different neural and non-neural 
cell types were present in the mutant NC tissues. Evidently, loss of Cdc42 or Rac1 were 
compatible with overt neuronal differentiation, such as in DRG and sympathetic ganglia 
(Fig. 3B, data not shown). Early glial differentiation was marked by the presence of fatty 
acid binding protein 7 (Fabp7) in both control and mutant satellite glia (Fig 3C). 
Furthermore, mutant NC-derived cells in the outflow tract region of the heart stained 
positive for smooth muscle actin, indicating that smooth muscle formed correctly (Fig 
3D,E). In addition to these differentiation markers, presence of Sox10-positive cells was 
seen in DRG and peripheral nerves (Fig. 3A). Sox10 is expressed in NC stem and 
progenitor cells and in the peripheral glial lineage. All markers investigated were present 
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at a comparable level to respective control animals in correlation to the size of the 
evaluated tissues. Furthermore, there were no signs of ectopic differentiation into a 
specific lineage. 
To further assess whether multipotency of NC cells was impaired, we generated NC 
explants from Cdc42 cko and control embryos in vitro. 20 hours after initial plating and 
outgrowth from the neural tube, NC explants were highly homogeneous for the NCSC 
markers Sox10 and P75 (Fig. 3F), but negative for differentiation markers (Paratore et al., 
2001; data not shown). Upon induction of differentiation over several days, mutant NC 
cells showed normal differentiation into neuronal, glial, and smooth muscle cell types 
(Fig. 3G-I). Moreover, no abnormalities were found in the cytoskeletal morphology of 
mutant eNCSCs (Fig. 3J). Taken together, we did not detect any signs of reduced or 
altered differentiation in Cdc42- and Rac1-deficient NC cells in vivo and of 
differentiation of Cdc42-deficient NC cells into diverse derivatives in vitro. We conclude 
that Cdc42 and Rac1 do not influence the capacity of NCSCs to acquire multiple different 
cell fates and to undergo initial steps of differentiation.
Cdc42 and Rac1 are essential for mitotic activity and cell cycle control in NC target 
structures
The broad phenotypes in mutant NC derivatives are consistent with the hypothesis that 
loss of Cdc42 and Rac1 both lead to a depletion of the NC cell pool. Accordingly, Cdc42
and Rac1 might play a role in promoting proliferation or they might be required for 
survival of NC cells. Assessing apoptosis within NC tissues at E10.5 and E11.5, however, 
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did not reveal signs of impaired survival in Cdc42 or Rac1 cko embryos (data not 
shown). Several reports have implicated Rho GTPases in cell cycle control (Narumiya 
and Yasuda, 2006). Thus, Cdc42 and Rac1 might be required for proliferation of NC 
cells. A reduction in mitotic activity would lead to a general loss of NC cells, reducing 
the overall cell pool size necessary for proper formation of NC derivatives. To investigate 
this possibility, we applied an antibody against phospho-histoneH3 (pH3) to examine 
proliferation in PA1 and 2 of Cdc42- and Rac1 cko embryos that expressed β-
galactosidase as a NC lineage label. pH3 is detected during G2 to M transition of the cell 
cycle when chromatin condensation occurs. Strikingly, while there was no statistically 
significant difference at E10.5 (Supplementary Fig. 3A,D), we saw a reduction in the 
number of pH3-positive cells by 24.5% (p < 0.05) in NC-derived tissue in Cdc42 mutants 
and by 19.6% (p < 0.05) in Rac1 mutants at E11.5 (Fig. 4A,D,G,H). As cell density per 
area was unchanged (Supplementary Fig. 4), these results demonstrate a reduced mitotic 
activity of mutant NC progenitor cells. Next, we examined whether loss of Cdc42 or 
Rac1 induced premature exit from the cell cycle in NC cells. To this end, a BrdU pulse 
was given 24 hours before analysis, followed by quantification of the relative number of 
cells that had incorporated BrdU into their DNA. BrdU-positive cells that did not express 
the proliferation marker Ki67 anymore have exited the cell cycle at the time point of 
analysis. Apart from the PA1 and 2, we examined the DRG of control and cko embryos, 
in order to analyze non-neural as well as neural derivatives of NC origin. At E10.5, no 
significant changes in cell cycle exit were found in DRG and in the PAs of Cdc42 and 
Rac1 cko embryos (Supplementary Fig. 3B,C,E,F,G). In contrast, we observed a drastic 
increase in cell cycle exit at E11.5 in both mutants: the number of DRG cells that had 
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exited the cell cycle was increased by 50.1% (p < 0.005) in Cdc42 and by 27.5% (p < 
0.05) in Rac1 mutants (Fig. 4C,F,I). In PA1 and 2, overall numbers of cell cycle exit were 
comparatively low. However, the increase in cell cycle exit amounted to 401.1% (p < 
0.05) in Cdc42 and 123.1% (p < 0.05) in Rac1 mutants, respectively (Fig. 4B,E). 
Taken together, we observed a reduction of mitotically active cells in both mutants, 
accompanied by a significant increase in cell cycle exit. Interestingly, these changes did 
not occur early in NC development, as mutant embryos at E10.5 showed no major 
alterations. This suggests that during early stages of NC development, NC cell 
proliferation might occur independently of Cdc42 and Rac1. These small Rho GTPases 
apparently turn into crucial regulators of proliferation, however, after NC-derived cells 
have reached their initial targets.
Stage-specific EGF responsiveness regulating small Rho GTPase-dependent self-renewal 
and proliferation
Knowledge of the mitogen acting upstream of Cdc42 and Rac1 might be necessary to 
understand how NC cells become dependent on these small Rho GTPases over time. In 
the CNS, expression of epidermal growth factor receptor (EGFR) increases during 
development, mediating a transition from mitotic FGF- to EGF-responsiveness in neural 
stem and progenitor cells (Ciccolini, 2001; Lillien and Raphael, 2000). To assess whether 
similar sequential changes occur during neural crest development, we first monitored the 
spatiotemporal expression of EGFR in vivo. At E9.5, EGFR expression was generally 
low, and Sox10-positive neural crest cells that migrated away from the neural tube did 
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not display EGFR expression (Supplementary Fig. 5A). At E10.5, EGFR expression –
although still relatively weak and heterogeneous– became apparent in DRG, the gut, and 
PA1 (Supplementary Fig. 5B-D). Strikingly, at E11.5, EGFR was very strongly and 
broadly expressed in DRG, the gut, and PA1. Moreover, Sox10-positive cells in DRG 
and the ENS co-expressed EGFR. To corroborate these findings on the cellular level,
explant cultures of NCSCs were prepared from distinct developmental stages (Material 
and methods). Both E9.5 neural tube and E11.5 organotypic gut explant cultures 
consisted of undifferentiated cells that expressed the NCSC markers Sox10/P75
(Supplementary Fig. 6; Paratore et al., 2001). Moreover, 99.6 ± 0.6% of all P75-positive 
cells in gut explants also expressed 4-integrin (data not shown), which identifies these 
cells as gut NCSCs (gNCSCs) (Bixby et al. 2002; Kruger et al., 2003). In agreement with 
the data obtained in vivo, eNCSCs from E9.5 neural tube explants did not express EGFR 
(Fig. 5A,B). In contrast, virtually all P75-positive cells in explants of E11.5 organotypic 
gut cultures expressed EGFR (Fig. 6A,B), demonstrating that, unlike eNCSCs, gNCSCs
express EGFR. To assess whether stage-specific EGFR expression correlated with factor 
responsiveness, eNCSCs and gNCSCs were exposed to FGF2 or EGF in defined culture 
conditions. In eNCSCs from neural tube explants, FGF2 but not EGF promoted 
proliferation, as assessed by quantification of mitogenic P75-positive cells (Fig. 5C). In 
contrast, gNCSCs were responsive to both mitogenic FGF2 as well as EGF (Fig. 6C). 
Thus, EGF is a stage-specific growth factor during NC development.
Since EGF is one of the factors that can lead to Cdc42 and Rac1 activation (Fanger et al., 
1997; Sini et al., 2004), we tested whether EGF-mediated proliferation in gNCSCs might 
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involve Cdc42 and/or Rac1. To this end, we measured the relative number of mitotic cells 
in explants of gNCSCs derived from either control, Cdc42 cko, or Rac1 cko E11.5 gut. 
Strikingly, proliferation of both Cdc42- and Rac1-deficient P75-positive cells was 
reduced to levels found in the absence of EGF (Fig. 6C), demonstrating that EGF-
induced proliferation requires Cdc42 and Rac1. In contrast, FGF2 –that unlike EGF is a 
mitogen for both eNCSCs and gNCSCs– promoted proliferation independently of Cdc42 
and Rac1. Thus, increased cell cycle exit and altered proliferation in Cdc42- and Rac1-
mutants in vivo (Fig. 4) can be explained by small Rho GTPase-dependent EGF signaling 
active at later but not early stage NC development.
The above experiments reveal a mitogenic role of EGF/small Rho GTPases in cultures 
containing NCSCs, but they do not directly address whether actual stem cell self-renewal 
is controlled by this signaling cascade. At early stages of NC development, combinatorial 
Wnt and BMP signaling, in the presence of FGF2, suppresses differentiation and 
maintains self-renewing multipotent eNCSCs from neural tube explants (Kleber et al., 
2005). As expected from our in vivo analysis (Fig. 2) and given that these early stage 
cells are not responsive to EGF (Fig. 5), deletion of Cdc42 and Rac1, respectively, did 
not affect self-renewing proliferation of eNCSCs (Fig. 5D; Supplementary Table 1). 
Indeed, neither the percentage of Sox10-expressing eNCSCs nor the number of 
mitotically active cells were diminished in mutant stem cell cultures (Supplementary 
Table 1). Unlike for early stage eNCSCs, factors instructively promoting stem cell 
maintenance at later stages of NC development remain to be identified (Kleber et al., 
2005). Nevertheless, the self-renewal capacity of later stage NCSCs can be monitored in 
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non-adhesive sphere cultures by serial sphere passaging (Molofsky et al., 2003). 
Therefore, to investigate the role of Cdc42 in gNCSC self-renewal, we generated ENS 
spheres from control and cko embryos at E12.5. As the embryonic gut might contain 
additional types of sphere-forming cells not related to the NC, we tracked NC-derived 
cells using the R26R reporter allele, so that spheres formed from recombined NC cells 
could be identified based on X-Gal staining. In agreement with fewer NC-derived cells 
being present in cko NC target structures (Fig. 2), the number of primary spheres 
generated from Cdc42 cko guts (sphere frequency) was reduced by 62.3% (p < 0.005) as 
compared to control spheres. Importantly, upon subcloning the amount of mutant 
secondary spheres that formed from recombined primary spheres was decreased by 
84.6% (p < 0.05), demonstrating a drastically decreased self-renewal capacity of gNCSCs 
(Fig. 6D). Moreover, while control spheres could be further subcloned, mutant ENS cells 
did not form tertiary spheres (data not shown). While sphere passaging reflects stem cell 
self-renewal, the sphere size is indicative of progenitor cell proliferation. Average sphere 
size was reduced in mutant spheres (primary spheres: control 137 ± 24µm, mutant 89 ± 
36µm; secondary spheres: control 150 ± 50µm, mutant 92 ± 17µm). In particular, spheres 
with a diameter larger than 100μm were reduced by 45.0% in primary and by 43.6% in 
secondary mutant spheres, reflecting reduced proliferation of ENS stem and progenitor 
cells in the absence of Cdc42 (Fig. 6D), confirming the data obtained with adhesive cko 
gut explant cultures (Fig. 6C). ENS sphere formation from Rac1-deficient ENS cells was 
equally reduced and spheres appeared smaller in size, too (data not shown), pointing to a 
similar requirement of Cdc42 and Rac1 in gNCSC self-renewal and progenitor cell 
proliferation. 
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Cdc42 and Rac1 appear to share a common pathway, with Rac1 being required for 
Cdc42 activation
The similar phenotypes of Cdc42 and Rac1 cko embryos in vivo and the indistinguishable
roles of these small Rho GTPases in EGF-dependent cell cycle regulation of gNCSCs 
suggests that Cdc42 and Rac1 might involve overlapping signaling pathways. To address 
this issue, we first compared alterations in downstream signaling events upon Cdc42- vs. 
Rac1-mutation in the NC by examining the expression profile of several key regulators of 
cell cycle dynamics. Quantitative real-time RT-PCR (qRT-PCR) was carried out with 
tissue from PA1 and 2 of Cdc42 and Rac1 cko and control embryos at E11.5. While 
expression of CyclinD1 and other regulators was not changed, P21Cip1 expression levels 
were significantly increased in both mutants (Supplementary Fig. 7), suggesting that 
Cdc42 and Rac1 might act as suppressors of P21Cip1 in NC-derived tissue. qRT-PCR 
analysis also revealed that loss of Rac1 but not of Cdc42 resulted in increased expression 
of Pten and c-Myc that have been associated with regulation of stem cell self-renewal 
(Groszer et al., 2006; Wilson et al., 2004). Although for technical reasons we were unable 
to confirm on the protein level the approx. 1.5 fold induction of P21Cip1 mRNA levels in 
the cko embryos, the overall data are consistent with the idea that Cdc42 and Rac1 might 
act in NC cells through partially overlapping downstream signaling targets. To directly 
assess whether Cdc42 and Rac1 pathways overlap, we examined levels of active (i.e. 
GTP-bound) forms of Cdc42 and Rac1 in the respective mutants. To this end, gNCSCs 
carrying two floxed alleles of either Cdc42 or Rac1 were expanded in sphere cultures in 
the presence of EGF, followed by adenovirus-Cre-mediated gene deletion. Cdc42
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ablation resulted in loss of total Cdc42 protein and of active Cdc42, as expected, whereas 
Rac1 activation was unchanged in Cdc42-deficient as compared to wild type cells (Fig. 
7). Intriguingly, however, loss of Rac1 caused reduced activation of both Rac1 as well as 
Cdc42, indicating that Cdc42 activation occurs downstream of Rac1. Thus, activation of 
Cdc42 and Rac1 appears to rely on overlapping pathways, likely explaining the similar 
phenotypes found upon Cdc42- and Rac1-inactivation in the NC.
Discussion
This report provides the first evidence for a crucial involvement of two small Rho 
GTPases, Cdc42 and Rac1, in NC development. Using mice with a deletion of either 
Cdc42 or Rac1 in the NC we show that proliferation and the balance between mitotically 
active and quiescent cells is Cdc42- and Rac1-dependent. Importantly, growth control 
during NC development is stage-specific: while self-renewing proliferation of eNCSCs is
Cdc42- and Rac1-independent, NC stem and progenitor cells after having reached their 
initial targets require these small Rho GTPases for cell cycle control. These 
developmental changes are associated with altered responsiveness of NC cells to 
mitogenic growth factors: eNCSCs emigrating from the neural tube are first FGF2 but not 
EGF responsive. At later stages, however, NC cells as analyzed in the ENS start to 
express the EGF receptor and acquire EGF responsiveness. Thereby, EGF but not FGF2
acts through Cdc42/Rac1 to promote proliferation. Thus, although endowed with a 
similar set of stem cell features, early and late NCSCs can be distinguished based on 
different mechanisms regulating proliferation.
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Proliferation control in NC stem and progenitor cells
So far, knowledge on how NC cell proliferation is controlled has been limited. In 
Xenopus, the helix-loop-helix transcription factor Id3 acts as a cell intrinsic regulator of 
NC cell proliferation and survival (Kee and Bronner-Fraser, 2005). However, in contrast 
to what we observed for Cdc42 and Rac1 in mice, Id3 in Xenopus appears to be involved 
already at the stage of NC induction. In mice, several Id genes with overlapping functions 
exist, but single and double knock-out mice display milder phenotypes than obtained 
upon loss of Id3 function in Xenopus. Thus, a direct implication of Id genes in Cdc42-
and Rac1-dependent NC proliferation appears unlikely. With respect to extracellular 
regulators of early NC cell proliferation, FGF2 promotes cell cycle progression in neural 
tube explant cultures, as shown here (Fig. 5), and the combined activities of Wnt and 
BMP in the presence of FGF2 allows expansion of multipotent eNCSCs by symmetrical 
cell division (Kleber et al., 2005). The latter involves canonical Wnt signaling via its 
downstream signaling component β-catenin (Büchmann-Møller S. and Sommer L., 
unpublished), which in astrocytes and skin progenitor cells can be regulated by Cdc42 
(Etienne-Manneville and Hall, 2003; Wu et al., 2006). In NC cells, however, β-catenin 
activity is only observed during early stages (Kleber et al., 2005), while it decreases in 
postmigratory structures such as DRG that are affected in Cdc42 and Rac1 cko embryos. 
Moreover, we demonstrate that Wnt, BMP and FGF2 are able to support eNCSC self-
renewal even in the absence of Cdc42 or Rac1 (Fig. 5; Supplementary Table 1). Thus, 
FGF2 and Wnt/β-catenin signaling in early NC cells is not associated with Cdc42/Rac1-
mediated cell cycle control. 
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At later stages, FGF2 is still a mitogenic signal for NC cells. However, unlike eNCSCs, 
later stage NC stem and progenitor cells also become sensitive to mitogenic EGF due to 
upregulation of the EGFR (Fig. 6; Supplementary Fig. 5). This is reminiscent of 
developmental changes occurring during CNS development, when neural stem cells 
switch from FGF2- to FGF2/EGF-responsiveness (Ciccolini, 2001; Lillien and Raphael, 
2000). Intriguingly, while FGF2-induced proliferation remains Cdc42/Rac1-independent 
during NC development, the mitogenic response of late stage gNCSCs to EGF can be 
abolished by either Cdc42- or Rac1-inactivation. Thus, EGF can be placed upstream of 
both Cdc42 and Rac1 in regulating cell cycle progression of NC cells that have reached 
their initial targets. 
The analogous proliferation phenotypes obtained in vivo and in cell culture upon Cdc42-
and Rac1-deletion in the NC raises the possibility that, downstream of EGF, Cdc42 and 
Rac1 share a signaling pathway to activate common targets. Indeed, the expression of 
P21Cip1 was similarly upregulated in NC tissue from Cdc42 and Rac1 cko embryos, while 
the expression of several other cell cycle regulators remained unaffected in both mutants 
(Supplementary Fig. 7). Conceivably, Cdc42 and Rac1 act through regulation of P21Cip1
to control cell cycle progression of late stage NC cells. However, Rac1- but not Cdc42-
deletion resulted in increased levels of Pten and c-Myc expression, indicating that Rac1 
might have a somewhat broader activity spectrum than Cdc42. This is consistent with our 
finding that Rac1 appears to act upstream of Cdc42: Levels of active Rac1 were 
unchanged in Cdc42-deficient NC cells, while active Cdc42 levels were reduced in the 
Rac1 ko (Fig. 7). Such cross-activation between Cdc42 and Rac1 has previously been 
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established in fibroblasts, although with reverse hierarchical order (Czuchra et al., 2005). 
Thus, Cdc42 and Rac1 can functionally interact, which in the NC appears to involve 
Cdc42 activation by Rac1 in a shared pathway mediating mitogenic EGF signaling.
In addition to EGF, several other receptor tyrosine kinases can signal through Rho 
GTPases. Of these, PDGFR plays a role in cranial and cardiac NC development, which 
has however not been attributed to the control of proliferation (Tallquist and Soriano, 
2003). ErbB2/3 activation by the growth factor neuregulin (NRG) promotes gliogenesis 
in NC cells and supports Schwann cell proliferation and differentiation. Interestingly, 
NRG-dependent Schwann cell proliferation is mediated by Cdc42 but not Rac1, pointing 
to distinct roles of these molecules in Schwann cell development (Benninger et al., 2007). 
The cell lineage-specific function of NRG and the differential activation of Cdc42 vs. 
Rac1 by NRG make it improbable that the effects described in our study involve NRG 
signaling. Finally, integrin signaling can also act as an activator of Cdc42 and Rac1 
(Schwartz and Shattil, 2000). However, ablation of integrin1 in the NC led to a milder 
phenotype than observed in Cdc42 and Rac1 cko embryos, in that mutant mice were 
viable up to 3 weeks of age with developmental abnormalities restricted to the PNS 
(Pietri et al., 2004). In sum, we cannot exclude that mitogenic Cdc42 and Rac1 are 
activated by distinct local signals in different NC derivatives. Such signals might, for 
instance, modulate mitogenic EGF and contribute to the distinct extent of cell cycle exit 
observed in mutant PA vs. DRG (Fig. 4). However, the broad phenotypes observed upon 
small Rho GTPase inactivation, similarly affecting virtually all NC derivatives, rather 
speak for a general mechanism of Cdc42- and Rac1-mediated growth control at later 
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stages of NC development. According to this model, EGF and Rac1/Cdc42 form a 
signaling cascade controlling the pool size of the NC population after its emigration from 
the neural tube, although this has to be confirmed by conditional inactivation of EGF 
signaling in NC derivatives.
Although Cdc42 and Rac1 have been implicated in migration control in other systems 
(Fukata et al., 2003), a cellular phenotype in the cko embryos became apparent only after 
E10.5, and emigration from the neural tube was apparently not affected in the absence of 
these small Rho GTPases. The in vivo situation was recapitulated in vitro by mutant 
eNCSCs that did not display any overt migration deficiencies in neural tube explant 
cultures. These findings are in agreement with recent reports demonstrating normal 
migration ability of Cdc42- and Rac1-null mutant fibroblasts, respectively (Czuchra et 
al., 2005; Vidali et al., 2006). Nevertheless, we cannot exclude a role of Rac1/Cdc42 in 
migration, such as during morphogenesis of craniofacial structures at later stages of NC 
development or in the full-length colonization of the gut during ENS formation (Stewart 
et al., 2007). Indeed, distal gut portions were not or less populated by NC-derived cells in 
mutants as compared to the control (Fig. 2), which –in addition to defective gNCSC 
proliferation and maintenance– could be associated with migration deficits. Of note, 
however, proliferation and directed migration are intricately linked during ENS 
development, with proliferation being the key mechanism driving invasion of the gut by 
NC cells (Simpson et al., 2007). Thus, small Rho GTPases might elicit associated 
functions in migration and proliferation. Importantly, the amenability of appropriate 
Small Rho GTPases in neural crest development – Fuchs et al 21
culture systems allowed us to demonstrate on the cellular level that Rac1 and Cdc42 
regulate NCSC proliferation cell autonomously and independently of migration.
Cdc42 and Rac1 functions are cell type- and stage-specific
Although small Rho GTPases have previously been implicated in regulating stem cells 
other than NCSCs, they do not execute a universal stem cell function. Rather, they show 
functional diversity depending on the type of Rho GTPase, the cell type, and the time of 
action. In the CNS, deletion of Cdc42 leads to progenitor cell depletion, but this is an 
effect secondary to gradual loss of polarity protein complex and adherens junctions
(Cappello et al., 2006). As a consequence, mutant cells fail to self-renew at the apical site 
of the neuroepithelium and therefore acquire a neurogenic fate. Such a mechanism 
unlikely contributes to the phenotypes described in our study, as expression of polarity 
protein complex was unaltered in Cdc42- or Rac1-deficient postmigratoy NC derivatives 
(data not shown). In the hematopoietic system Rac1 is required for the retention of 
hematopoietic stem cells and progenitors (HSC/Ps) in their microenvironmental niche, 
but an effect on proliferation was only observed in vitro and not in vivo (Cancelas et al., 
2005). Deletion of Cdc42 in HSC/Ps also led to impaired retention, but mutant HSC/Ps 
showed increased cell cycle entry, thus increasing the number of HSC/Ps (Yang et al., 
2007). Apparently, in the hematopoietic system, the function of Cdc42 in cell cycle 
control is the inverse of its role in the NC. In skin progenitor cells, Rac1 plays a very 
different role from Cdc42. Similar to its role in late stage NCSCs, Rac1 is crucial for 
maintenance of skin stem cells present in the hair follicle, but possibly not of 
interfollicular epithelial stem cells (Benitah et al., 2005; Castilho et al., 2007; Chrostek et 
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al., 2006). In contrast, unlike in NCSCs, Cdc42 controls differentiation of progenitor cells 
into hair follicle cells (Wu et al., 2006). In sum, there is increasing evidence that the 
function of a given small Rho GTPase is specific for the type of stem and progenitor cells 
(Wang and Zheng, 2007). The present study now also reveals stage-specific roles of 
small Rho GTPases in stem cells. During NC development, Cdc42 and Rac1 activities 
mark a transition in NCSC growth control, acting as critical cell cycle regulators of 
virtually the entire pool of NC cells after emigration from the neural tube. Similarly, 
NCSCs from different developmental stages display intrinsic differences in their 
responsiveness to fate-promoting cues (Bixby et al., 2002; Kleber et al., 2005). However, 
while signals inducing differentiation are also differentially interpreted depending on the 
location, the control of proliferation appears to be more general in late stage NC stem and 
progenitor cells, leading to broad developmental defects in NC derivatives upon Cdc42
and Rac1 inactivation. 
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Materials and methods
Generation of cko mice
Animals homozygous for the floxed Cdc42 allele (Cdc42lox/lox) (Wu et al., 2006) were 
mated with mice heterozygous for the floxed allele that additionally carried the Wnt1-Cre
transgene (Danielian et al., 1998) (Wnt1-Cre/Cdc42lox/wt). Offspring with a Wnt1-
Cre/Cdc42lox/lox genotype were termed Cdc42 cko embryos, while littermates lacking the 
Wnt1-Cre transgene or carrying a wild type Cdc42 or Rac1 allele did not exhibit any 
overt phenotype, thus serving as control animals. For in vivo fate mapping of recombined 
cells, the R26R allele (Soriano, 1999) was bred into Cdc42lox/lox mice which where mated 
with Wnt1-Cre/Cdc42lox/wt mice to obtain Cdc42 cko and control embryos that expressed 
-galactosidase upon Cre-mediated recombination. The same breeding strategy was used 
for Rac1lox/lox animals (Chrostek et al., 2006) to obtain Rac1 cko and control embryos. 
Genotyping was done by PCR on genomic DNA.
Histochemistry, immunofluorescence and X-Gal staining
Hematoxylin-eosin stainings (HE) were done on paraffin sections. Immunofluorescence 
stainings were done on paraffin (7μm) or cryo (10-12μm) sections. For all antibody 
stainings on sections, except for Cdc42, Rac1 and Sma, antigen retrieval was done with 
10mM citrate buffer in a steam cooker device at 110 C for 5 min. Fixation was done with 
4% para-formaldehyde (PFA) for sections and 4% formaldehyde for cells in PBS for 
10min at room temperature with the following exceptions: Fixation for Cdc42 staining on 
cryo sections was with pre-chilled 4% PFA for 10min on ice. Fixation for Rac1 stainings 
on cryo sections was with pre-chilled 4% PFA/2% acetic acid in PBS for 10min followed 
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by pre-chilled ethanol:acetic acid (95:5) for 2min, all on ice. Antibodies and substrates 
used for stainings are given in Supplementary Table 2. BrdU incorporation was done 
according to the manufacturer’s instructions (Roche). X-Gal (Applichem) stainings were 
done according to standard protocols.
Cell culture
eNCSC explant cultures from E9.5 trunk neural tubes were done as described (Lee et al., 
2004). Migratory capacity of eNCSCs in vitro (migration index) was determined as 
described (Hari et al., 2002). Cultures were incubated in defined medium (DM), 
supplemented with 10ng/ml FGF2. For eNCSC maintenance experiments, medium was 
switched after 20 hours to DM with 10ng/ml FGF2, 200ng/ml Wnt1 and 50ng/ml BMP2. 
To assess growth factor response of eNCSCs, medium was withdrawn after 16 hours, 
cells were starved for 2 hours in DM and subsequently pulsed with DM plus 50ng/ml 
FGF2 or 50ng/ml EGF, respectively, for additional 2 hours. gNCSC explant cultures 
were obtained from isolated E11.5 guts. Culture conditions were similar to eNCSC 
explant cultures with the following exceptions: Cultures were incubated for 24 hours in 
DM with 10ng/ml FGF2, 10ng/ml EGF and 10ng/ml GDNF. To assess growth factor 
response of gNCSCs, medium was withdrawn after 24 hours, cells were starved for 2 
hours in DM and subsequently pulsed with DM plus 50ng/ml FGF2 or 50ng/ml EGF, 
respectively, for additional 3 hours. gNCSC spheres were grown from E12.5 control and 
mutant ENS cells. Isolated guts were dissociated into single cells with 1mg/ml 
collagenase type I (Worthington) dissolved in HBSS w/o Ca and Mg. Selective growth of 
NC-derived cells was accomplished with NC-specific sphere (NCS) medium and verified 
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by visualization of the lineage marker -galactosidase. NCS medium contained DMEM-
F12, 20ng/ml FGF2, 20ng/ml IGF1, 20ng/ml EGF, 10ng/ml GDNF (all Peprotech), 1% 
N2 supplement, 2% B27, 1% Penicillin/Streptomycin (all Invitrogen), 50μM 2-
mercaptoethanol and 15% chicken embryonic extract. Poly(2-hydroxyethyl 
methylacrylate) (Sigma) was used to coat culture plates to eliminate adhesion of cells to 
the plastic surface. To assess self-renewal, secondary spheres were cultured from defined 
numbers of cells obtained from dissociated primary spheres. The average number of 
cells/primary spheres was used to calculate the ratio between secondary and primary 
spheres.
Quantitative real-time RT-PCR
Total RNA from E11.5 PA1/2 cells was isolated with the TRIZOL protocol (Invitrogen)
according to the manufacturer's instructions, and 2 µg was used for each cDNA synthesis. 
cDNA synthesis was performed using Ready-To-Go You-Prime First-Strand Beads 
(Amersham). The same amount of cDNA was used for each PCR reaction. qRT-PCR was 
performed in a Lightcyler (Applied Biosystems) using Master SYBR Green kit 
(ABgene). Each result was normalized by the housekeeping 18S gene expression. The 
primer pairs used for each PCR can be found in Supplementary Table 3.
Rac1-GTP and Cdc42-GTP pull down assays
gNCSC spheres were grown from E12.5 wild type, Cdc42lox/lox and Rac1lox/lox guts as 
mentioned above. Adenovirus-Cre-mediated recombination was done by infecting single 
cell suspensions of secondary spheres. Infected cells were cultured to form tertiary 
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spheres. Medium was washed off 4 days after infection and replaced with virus-free NCS 
medium for additional 2 days. GST-PAK-CD constructs were provided by J. Collard 
(The Netherlands Cancer Institute, Amsterdam, Holland). Rac1 and Cdc42 activities were 
measured as described (Benninger et al., 2007). 
Statistical analysis
Each experiment was performed with at least three independent samples. Statistical 
significance was tested with the unpaired Student’s t-test.
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Figure 1
Similar developmental defects in NC-derivatives of Cdc42 and Rac1 cko embryos.
(A,B) Exon 2 (E2) of the Cdc42 locus and Exon 3 (E3) of the Rac1 locus, respectively, 
are flanked by loxP sites (floxed allele) and deleted (null allele) in NC cells upon 
breeding with Wnt1-Cre mice. (C,D) Loss of Cdc42 and Rac1 protein, respectively, in 
mutant NC cells populating pharyngeal arch 1 (PA1) at E10.0. (E) Sagital median cleft in 
Cdc42 and Rac1 cko embryos shown on transverse sections at the level of the frontonasal 
process. (F) Mutant DRG are present but appear reduced in size (white arrows) when 
compared to DRG in a control embryo (black arrow). (G) Failure of aortico-pulmonary 
septum formation in the heart outflow tract of cko embryos. Scale bars, (C,D) 100μm, (E-
G) 200μm. Ao, ascending aorta; PT, pulmonary trunk; TA, truncus arteriosus.
Figure 2
Cdc42 and Rac1 are not required for migration of NC cells to initial target structures.
(A,B) In vivo fate mapping of NC cells in E10.5 cko and control (co) embryos. NC cells 
expressing β-galactosidase from the R26R Cre-reporter allele were visualized by whole 
mount X-Gal stainings. Cdc42 and Rac1 cko embryos show normal distribution of NC 
cells. Arrowheads point to the first PAs populated by NC cells. Enlarged areas marked by 
boxes show presence of DRG and peripheral nerves. (C-F) Histological sections of E12.5 
Cdc42 control and cko embryos stained with X-Gal show that NC cells have reached 
various targets such as nasofrontal structures (C), the eye (D), dorsal root ganglia (DRG), 
(E) and proximal parts of the midgut (F; arrowhead). Note DRG size reduction and lack 
of distal gut colonization (open arrowheads), pointing to reduced numbers of mutant vs. 
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control NC-derived cells in these structures. Similar histological data were obtained with 
Rac1 cko embryos (not shown). Scale bars, 200μm.
Figure 3
Loss of Cdc42 and Rac1 does not interfere with differentiation of NC cells.
(A) Expression of Sox10 in cells within the DRG of control and cko embryos. (B)
Presence of neuronal differentiation in mutant DRG. (C) Satellite glia in DRG express the 
early glial marker Fabp7. (D-E) Although aortico-pulmonary septa in the mutants fail to 
form, cardiac NC-derived cells in the outflow tract region of the heart have generated 
smooth muscle cells expressing Sma (arrows). Near adjacent sections were stained with 
X-Gal for localization of cardiac crest cells revealed by in vivo fate mapping using the 
R26R Cre-reporter allele. Blood cells are marked with an asterisk (*). (F) Cdc42-
deficient eNCSCs express the NCSC markers Sox10 and P75 after outgrowth from the 
neural tube. Normal differentiation of Cdc42-deficient eNCSCs into neuronal (G), glial 
(H) and smooth muscle (I) cell types upon induction of differentiation. Cdc42-deficient 
eNCSCs show normal cytoskeletal morphology (J). Scale bars, (A-E) 50μm, (F-J) 10μm.
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Figure 4
Reduced mitotic activity and increased cell cycle exit in NC-derived structures of Cdc42
and Rac1 cko embryos at E11.5.
(A,D) Reduced numbers of mitotic cells in mutant PA 1 and 2 as detected by pH3 
staining at E11.5. (G,H) PA1 tissue within quantified regions is largely X-Gal positive, 
demonstrating the neural crest origin of the vast majority of cells. Black and white arrows 
mark pharyngeal ectoderm and core mesoderm. These tissues are not NC-derived and 
were excluded from the quantification. (B,E) Cell cycle exit was quantified 24 hrs after a 
BrdU pulse. Cells having exited the cell cycle show incorporation of BrdU but no 
expression of the proliferation marker Ki67. NC cells that have populated PA1 and 2 
show an increase in cell cycle exit at E11.5. (C,F,I) Cells in mutant DRG show 
significantly increased cell cycle exit at E11.5. Values represent mean ± SEM. Scale bars, 
50μm. (*) p<0.05; (***) p<0.005.
Figure 5
Lack of EGF responsiveness in eNCSCs
eNCSC explants were generated by outgrowth from E9.5 neural tubes. eNCSCs 
homogeneously express the NCSC markers Sox10 and P75 (A,B”), but do not express 
EGF receptor (EGFR) (B,B’). (B) is an overlay of the stainings shown in (B’) and (B”). 
(C) Following outgrowth from the neural tube, wild type eNCSCs were challenged with 
either FGF2 or EGF. The number of P75-expressing mitotic eNCSCs in response to these 
factors was quantified by pH3 staining. While FGF2 led to an increase in mitotic cells, 
EGF-treated mitotic cells remained at levels comparable to non-treated control cells 
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(n.a.). White arrowheads mark pH3-positive nuclei. (D) eNCSCs were expanded and 
maintained in the presence of Wnt1, BMP2, and FGF2. Numbers of cells expressing the 
stem cell marker Sox10 and the proliferation marker Ki67 are comparable in Cdc42
mutant (Cdc42 cko) and control (co), demonstrating that self-renewal and proliferation of 
the early population of NCSCs are not affected. Values represent mean ± SEM. Scale 
bars, 10μm. (**) p<0.01.
Figure 6
EGF acts via Cdc42 and Rac1 to promote cell proliferation of gut NC stem and 
progenitor cells.
gNCSC explants were generated by outgrowth from E11.5 gut. In addition to the NCSC 
markers Sox10 and P75 (A,B”), explant cells homogeneously express the EGF receptor 
(EGFR) (B,B’). (B) is an overlay of the stainings shown in (B’) and (B”). (C) Following 
outgrowth from the gut, control (co), Cdc42 cko, and Rac1 cko enteric NC cells were 
challenged with either FGF2 or EGF. The number of P75-expressing mitotic gNCSCs in 
response to these factors was quantified by pH3 staining. FGF2 induced proliferation in 
both control and mutant cells. However, EGF induced proliferation only in control but 
not Cdc42- and Rac1-deficient gNCSCs. Pictures for treatment with EGF are shown. 
White arrowheads mark pH3-positive nuclei. (D) Control and Cdc42-deficient enteric 
spheres were generated from E12.5 guts. The percentage of spheres with a diameter 
larger than 100μm is lower in mutants (1˚ sphere size, 2˚ sphere size), indicating reduced 
proliferation. In addition, the self-renewal capacity is significantly reduced in mutants. 
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Values represent mean ± SEM. Scale bars, 10μm. (*) p<0.05; (**) p<0.01; (***) 
p<0.005.
Figure 7
Cdc42 and Rac1 appear to act in a common pathway, with Rac1 being an upstream 
activator of Cdc42.
Western blots and pull-down assays using GST-PAK-CD constructs were done with 
lysates from Adenovirus-Cre-infected enteric spheres. Infected spheres were wild type 
(co) or carried two floxed alleles for Cdc42 (Cdc42 ko) and Rac1 (Rac1 ko), respectively. 
(A) Total Cdc42 was significantly reduced in Cdc42 ko as compared to co lysates (left 
panel). Levels of active GTP-bound Cdc42 were reduced in both Cdc42 ko and Rac1 ko 
as compared to control (right panel). (B) Total levels of Rac1 were significantly reduced 
in lysates from Rac1 ko (left panel). Activity of Rac1 was significantly lower in Rac1 ko 
but not in Cdc42 ko as compared to control (right panel). (***) p<0.005.
During vertebrate development, neural crest cells migrate to distant sites of the 
embryo, where they differentiate into a variety of specialized cell types. Both 
migratory neural crest cells and their target structures contain neural crest-derived 
stem cells (NCSCs), raising the question of how stem cell proliferation vs. 
differentiation are controlled in space and time. Intriguingly, NCSCs change their 
growth requirements during development, in that late, but not early stage NCSCs 
become responsive to the growth factor EGF acting upstream of the small Rho 
GTPases Cdc42 and Rac1. Thus, expansion of NCSCs is regulated in a stage-specific 
manner.
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Supplementary Figure 1
Conditional deletion of Cdc42 and Rac1 in neural crest using Wnt1-Cre mediated recombination. 
(A) Proof of genomic recombination in NC-derived cells in PA1 by PCR: An embryo 
homozygous (fl/fl) for the floxed Cdc42 allele carries the null allele in Wnt1-Cre (CRE +) 
recombined tissue. Unrecombined (CRE -) tissue from the same embryo harbors the floxed 
allele. In an embryo heterozygous for the floxed allele, the wild type (wt) allele is additionally 
detected in CRE + and CRE – tissues. Recombinant tissue was identified and isolated based on 
Cre-mediated β-galactosidase expression from the R26R allele. The same approach was used to 
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proof genomic recombination of Rac1 in NC-derived cells of PA1 (B). (C,D) Cdc42 and Rac1 
cko embryos display a highly penetrant phenotype. Morphological malformations only became 
apparent at stages later than E10.5. The occurrence of cko embryos was within the range of the 
expected Mendelian ratio until E13.5. At E13.5 necrotic cko embryos were frequent, and no cko 
embryos were detected in litters from later stages. n, number of embryos.
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Supplementary Figure 2
Quantification of in vitro outgrowth from the neural tube did not reveal differences in emigration 
of eNCSCs. E9.5 control and cko neural tubes were isolated and plated into cell culture dishes. 
The extent and size of the forming explant is indicative of the migratory capacity of eNCSCs. 
The migratory index was determined 20 hrs after initiation of the cultures. Values are 
standardized to control and represent mean ± SEM. Scale bars, 200μm. nt, neural tube.
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Supplementary Figure 3
Mitotic activity and cell cycle exit are not changed in neural crest structures of cko embryos at 
E10.5.
(A,D) No reduction of mitotic cells in mutant PA1 and 2 is detected by pH3 staining at E10.5.
Cell cycle exit was quantified 24 hrs after a BrdU pulse had been given. Cells having exited the 
cell cycle show incorporation of BrdU but no expression of the proliferation marker Ki67. (B,E)
Cell cycle exit in mutant neural crest cells in the pharyngeal arches is not significantly altered at 
E10.5. (C,F,G) Cells in mutant DRG do not show significantly increased cell cycle exit at E10.5. 
Scale bar, 50μm. 
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Supplementary Figure 4
Cell density within PA1 and 2 is not changed in Cdc4 and Rac1 cko embryos.
Cell density at E10.5 and E11.5 was determined by quantification of cell nuclei (visualized with 
DAPI) per defined area. Average cell densities for each stage and genotype are shown as relative 
values ± SEM , normalized to the corresponding controls.
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Supplementary Figure 5
Temporal expression of EGFR in NC cells and NC target structures in vivo
(A) Emigrating NCSCs at E9.5 express Sox10 (white arrowhead) while expression of EGFR is 
not detectable (open arrowhead), as analyzed by immunohistochemistry on paraffin-embedded 
thin sections. (B) Sox10-expressing NC cells in DRG at E10.5 do only weakly display EGFR
expression. Strikingly, a significant increase in EGFR expression is seen at E11.5 (white 
arrowhead). (C) Similarly, EGFR levels in Sox10-expressing enteric cells are low at E10.5 in the 
gut, while its expression strongly increases at E11.5 (white arrowhead). Inset shows negative 
tissue on same embryo section. (D) Cells in PA1 display an increase of EGFR, from absent or 
low levels at E10.5 to high levels at E11.5 in virtually all PA cells. In (A-C), right panels 
represent overlays of Sox10- and EGFR-stainings. nt, neural tube; DRG, dorsal root ganglia; 
ENS, enteric nervous system; PA1, pharyngeal arch 1. Scale bar, 25μm.
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Supplementary Figure 6
NC explant cultures from different developmental stages display similar NCSC marker 
expression and developmental potential.
NC explants were generated from E9.5 neural tubes and E11.5 guts (low magnification 
overviews in upper panels). Both, eNCSC explants from the neural tube and gNCSC explants 
from the gut homogeneously express the NCSC markers Sox10 and P75 (middle panels). Sox10-
and P75-expressing gut cells additionally express α4-Integrin (data not shown). Cells expressing 
these markers have been identified as gNCSCs (Kruger et al., 2003). Both eNCSC and gNCSC 
explants did not display any evidence for neuro- and gliogenesis (data not shown). Upon 
induction of differentiation with fetal calf serum (FCS) and forskolin (lower panels), cells adopt 
neuronal traits (NF160) or display continued Sox10 expression. nt, neural tube. Scale bars, 
50μm.
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Supplementary Figure 7
Altered expression of cell cycle regulatory genes in Cdc42- and Rac1-deficient neural crest cells.
Relative mRNA abundance was measured by qRT-PCR from PA1 and 2 tissue at E11.5. Shown 
is expression in cko tissues relative to expression in control tissues. The cell cycle inhibitor 
P21Cip1 is upregulated in both mutants. Rac1 cko
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Supplementary Table 1
eNCSC self renewal and proliferation
      Self renewal
Sox10+ cells/ total cells (% ± s.d.)
co 93.7 ± 3.0
Cdc42 cko 93.3 ± 5.3
co 93.9 ± 1.4
Rac1 cko 93.2 ± 1.8
      Proliferation
Ki67+Sox10+ cells/ total Sox10+ cells (% ± s.d.)
co 93.3 ± 7.1
Cdc42 cko 89.3 ± 9.0
co 97.4 ± 0.7
Rac1 cko 97.2 ± 0.6
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Supplementary Table 2
Antibody/Substrate Dilution, Source
mouse Sox10 1:200, R&D
mouse NF160 1:400, Sigma
rabbit NF160 1:400, Chemicon
rabbit Fabp7 1:5000, a kind gift of C. Birchmeier
mouse Sma 1:500, Sigma
rabbit S100 1:200, Dako
rabbit Ki67 1:100, Dako
mouse α-tubulin 1:250 Sigma
phalloidin 1:250, Invitrogen
mouse BrdU 1:10, Roche
rabbit pH3 1:200, Upstate
mouse pH3 1:200, Upstate
sheep EGFR 1:200, Upstate
mouse Cdc42 1:100, SantaCruz
mouse Rac1 1:200, Upstate
Fluorescence-conjugated secondary antibodies were from Jackson Immunoresearch.
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Supplementary Table 3
Quantitative real-time RT-PCR primer sequences
P53 forward: TTT TTA TGG CGG GAA GTA GAC TG 
P53 reverse: GCG TAA ACG CTT CGA GAT GTT  
CyclinE forward: GTG GCT CCG ACC TTT CAG TC
CyclinE reverse: CAC AGT CTT GTC AAT CTT GGC A
P19 forward: CTG AAC CGC TTT GGC AAG AC 
P19 reverse: GCC CTC TCT TAT CGC CAG AT  
P27 forward: CCG GGC CGA AGA GAT TTC TG  
P27 reverse: TCA AAC GTG AGA GTG TCT AAC G   
CyclinD1 forward: CTC CTC TTC GCA CTT CTG CTC 
CyclinD1 reverse: GCG TAC CCT GAC ACC AAT CTC 
CyclinD2 forward: GAG TGG GAA CTG GTA GTG TTG 
CyclinD2 reverse: CGC ACA GAG CGA TGA AGG T
Cdk2 transcript variant 1 forward: TGT ACC CAG CAC CAT GCT AAG 
Cdk2 transcript variant 1 reverse: CCG GAA GAG TTG GTC AAT CTC A 
Cdk2 transcript variant 2 forward: TTT GCT GAA ATG GTG ACC CG 
Cdk2 transcript variant 2 reverse: TCC CCA GAG TCC GAA AGA TCC
Cdk4 forward: ATG GCT GCC ACT CGA TAT GAA
Cdk4 reverse: TCC TCC ATT AGG AAC TCT CAC AC
P21 forward: CCT GGT GAT GTC CGA CCT G
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P21 reverse: CCA TGA GCG CAT CGC AAT C 
Pten forward: TGG ATT CGA CTT AGA CTT GAC CT
Pten reverse: GCG GTG TCA TAA TGT CTC TCA G
18S forward: GTT CCG ACC ATA AAC GAT GCC 
18S reverse: TGG TGG TGC CCT TCC GTC AAT 
CyclinA2 forward: GCC TTC ACC ATT CAT GTG GAT
CyclinA2 reverse: TTG CTG CGG GTA AAG AGA CAG
CyclinB2 forward: CTC AGG GTC ACT AGG AAC ACG
CyclinB2 reverse: AGC TCT TCG CTG ACT TTA TTA CC
c-Myc forward: TCT CCA TCC TAT GTT GCG GTC
c-Myc reverse: TCC AAG TAA CTC GGT CAT CAT CT
Cdk6 forward: GTT CAG ACG TGG ATC AAC TAG G
Cdk6 reverse: GAG CAG ATT TGG AAT GAA AAG CC
Rac1 forward: TGA ATC TGG GCC TAT GGG ACA
Rac1 reverse: GGA CTC ACA AGG GAA AAG CAA A
Cyclin E forward: GTG GCT CCG ACC TTT CAG TC
Cyclin E reverse: CAC AGT CTT GTC AAT CTT GGC A
Cdc42 forward: CCT TTC TTG CTT GTT GGG ACC
Cdc42 reverse: GGC TCT TCT TCG GTT CTG GAG
